PKC, protein kinase C; ROS, reactive oxygen species; Cyt c, cytochrome c; PI, propidium iodide; H 2 DCFDA, dichlorodihydrofluorescein diacetate.
Introduction
Apoptosis is a form of programmed cell death with important roles in a wide variety of mammalian physiological processes and, when inappropriately controlled, is responsible for several pathologies. A crucial feature of mammalian apoptosis is the permeabilization of membrane organelles, namely mitochondria, and the release of apoptogenic factors that leads to activation of proteases responsible for cell death. The Bcl-2 family is critical for regulation of this permeabilization. The pro-apoptotic members of this family Bax and Bak are membrane multidomain proteins essential for the completion of apoptosis, since their deletion completely impairs this process [1] . Despite the importance of these proteins, the mechanisms by which they are regulated are not fully understood.
The pro-apoptotic function of Bax depends on its ability to translocate, oligomerize and insert into the mitochondrial membrane following stress [2] [3] [4] . Modulation of Bax can occur by phosphorylation, a post-translational modification. Indeed, it has been reported that phosphorylation of different Bax residues modulates its activity. Phosphorylation of ser184 by protein kinase B (Akt/PKB) and protein kinase C (PKC) [5] [6] [7] promotes cell survival that is prevented by dephosphorylation by the protein phosphatase 2A [8] . Phosphorylation of ser163 by glycogen synthase kinase 3 (GSK3) [9] and of thr167 by JNK and p38 kinase [10] lead to Bax activation and cell death. Bax can also be regulated by interaction with other proteins, thus preventing its translocation to mitochondria and hindering its cytotoxic effect. Bax-interacting proteins identified so far are, among others, Bcl-2 and its homologous proteins [11, 12] , adenine nucleotide translocator [13] , voltage-dependent anion channel protein [14] , humanin [15] , 14-3-3 [16] , heat shock protein Hsp60 [17] , PKC [18] , and Asc [19] .
The PKC family is a multigene family of serine/threonine kinases with at least ten isoforms.
They are classified into three subfamilies based on their structure and cofactors required for activation: the conventional or classical (, I, II and ), the novel (, , , and ) and the atypical ( and /) isoforms [20] . PKC isozymes are ubiquitously expressed, and PKC, , and  are the most abundant isozymes in various tissues [21] . Although PKCs have a clear role in cell death, it has been a challenge to establish the relative contribution of the individual isoforms, owing to the different roles of PKC isoforms according to cell type and cellular localization [22] .
Growing evidence indicates that PKC family members play important roles in regulating cell survival and apoptosis (for a review see 23) and their role in the modulation of Bcl-2 family has been the subject of increased attention.
Although several reports suggest a pro-survival role for PKC, conflicting data indicating a proapoptotic function have been reported. In several cell lines, both depletion of PKC or expression of a dominant negative form of PKC lead to apoptosis induction [24] [25] [26] [27] . PKC phosphorylates Bcl-2 at serine 70, which is required for functional suppression of apoptosis in murine growth factor dependent cell lines [28] . Other reports show induction of apoptosis in the presence of PKC. PKC was shown to mediate activation of caspase-3 in renal proximal tubule cells [29] and to mediate Lamin B phosphorylation in HL60 cells [30] . In human prostate cancer cells, the presence of PKC in non-nuclear membranes was associated with apoptosis, while its absence resulted in resistance to apoptosis [31] . In the same cell line, Tanaka and colleagues [32] showed that p38 MAPK mediates PKC-induced apoptosis and that PKC leads to dephosphorylation and inactivation of the survival kinase AKT, probably mediated by protein phosphatase 2A.
While studies of mammalian cell lines lacking specific components of the apoptotic machinery or isoforms of the PKC signalling cascade have contributed substantially to our understanding, it would be almost impossible to use cells with all the relevant genes silenced or knocked out.
Yeast lacks obvious homologues of many key mammalian apoptotic regulators, including the Bcl-2 family, and it has therefore been used as an "in vivo" system to study several of these apoptotic regulators. Indeed, when many of these proteins are expressed in yeast, they conserve their functional and molecular effect at several cellular levels, namely at the mitochondria (for a review see 33 and 34) . In the present study, we used yeast to investigate the role of PKC in the regulation of the pro-apoptotic Bcl-2 family protein Bax. Our results demonstrate that PKC increases the translocation and insertion of Bax c-myc (a form of Bax in the active conformation) into the yeast mitochondria by a mechanism independent of the PKC kinase activity.
Material and methods

Yeast strains, plasmids and growth conditions
The wild-type haploid Sacharomyces cerevisiae strain CG379 (mat  ade5 his7-2 leu2-112 tryp1-289 ura3-52 [kil-O], yeast genetic stock center, University of California, Berkeley, USA) was used throughout this study. For PKC expression, the bovine PKC was cloned into the YEp51 yeast expression plasmid (LEU2) under the control of a GAL10 promoter. For Bax c-myc expression, the isoform  of the human bax gene was chemically synthesized with yeast codon bias and fused to the c-myc epitope cloned into the centromeric plasmid pCM184 (TRP1) under the control of a Tet-Off promoter (repressed by the addition of doxycycline) as described in [35] .
The GFP-Atg8p construction (as described in 36) is in the pRS416 plasmid under control of the endogenous Atg8p promoter. Site directed mutagenesis of bovine PKC was done using the QuickChange method (Stratagene) with the primers GAGCTGTACGCCATCCGTATCCTGAAGAAGGACGTGG and CCACGTCCTTCTTCAGGATACGGATGGCGTACAGCTC. The mutant PKC was sequenced to verify the introduction of the desired substitution. pCLbGFP (URA3), encoding GFP fused to the mitochondrial presequence of citrate synthase (mt-GFP) under the control of the GAL1/10 promoter was used to monitor mitochondrial morphology [37] . Expression of PKC and Bax c-myc was done sequentially. Yeast cells were first grown in synthetic medium (0.17% yeast nitrogen base, 0.5% ammonium sulphate, 0.1% potassium phosphate and 80 g/ml of all auxotrophic requirements except leucine and tryptophan, pH 5.5) with 2% glucose, 10 g/ml of doxycycline to repress Bax c-myc expression. Cells were then transferred to synthetic medium with 2% galactose, 1% raffinose, 3% glycerol and 10 g/ml doxycycline to induce PKC expression and grown to an OD at 640 nm of 1.0. Finally, cells were transferred to synthetic medium with 2% galactose without doxycycline and diluted to an OD at 640 nm of 0.1 to induce both proteins. Cells were collected at different times and processed further. All incubations were performed at 30ºC, 200 r.p.m. The PKC inhibitors Gö 6976 (Sigma) and Ro 32-0432 (Sigma) were prepared in dimethyl sulfoxide (DMSO) at a final concentration of 1 mM. Cells were transferred to synthetic medium with 2% galactose without doxycycline and diluted to an OD at 640 nm of 0.1, to express both proteins, and DMSO, Gö 6976 or Ro 32-0432 were added to the culture at a final concentration of 0.1% and 1M, respectively. Cell survival was measured by platting efficiency as described above.
Cell death assay and effect of PKC inhibitors on cell death
PI staining and ROS production
Propidium iodide (PI) staining and ROS production were monitored by flow cytometry.
Labelling with PI was performed by incubating 10 6 cells in culture medium containing 2 g/ml 
Mitochondrial network fragmentation
Cells expressing PKC, Bax c-myc, PKC and Bax c-myc or none of the proteins (control) were co-transformed with pCLbGFP. Cells were collected at different times and fragmentation of the mitochondrial network evaluated by epifluorescence microscopy. At least 150 cells per sample were classified. In this set of experiments uracil was also omitted from the growth medium.
Western blot analysis
Cells extracts were prepared as described in [38] . Protein lysates were separated on 12.5% SDS-PAGE gels and transferred to polyvinylidene fluoride membranes (hybond-P; Amersham). The membranes were blocked with 5% non-fat milk in phosphate-buffered saline containing 0.05% 
Mitochondria preparation, carbonate treatment and cyt c content analysis
Mitochondria were isolated by differential centrifugation from zymolyase-treated cells, as described previously [39] . For carbonate and Triton X-100 extraction, 1 mg of protein from isolated mitochondria was incubated in the presence of 0.1 M Na 2 CO 3 (pH 10.0) or Triton X-100 for 15 minutes and centrifuged for 15 minutes at 105,000g. The presence of Bax c-myc in the pellet and the supernatant was verified by western blot.
Assessment of cyt c content was measured by redox spectra of isolated mitochondria essentially as described previously [40] . Differential spectra of the reduced (sodium dithionite) minus oxidized (potassium ferricyanide) extracts were recorded on a double-beam/double wavelength spectrophotometer (Aminco DW2000). The maxima absorption for cyt b and for cyt c+c1 used were 561 and 550 nm, respectively. The cyt c/cyt b ratio was always used to normalize the total protein content from the different samples.
Immunoprecipitation and detection of phosphorylated serines
Immunoprecipitation was performed using the IP50 kit from Sigma as described in [41] . Briefly, cells were ressuspended in buffer (Tris-malate ALEXIS Biochemicals), and the other was probed with a polyclonal anti-Bax antibody.
[ 32 P] Phosphate labelling
For phosphate labelling, expression of PKC and Bax c-myc were done in a low phosphate medium [42] as in [41] . Briefly, 32 P phosphate (0.25mCi/ml) was added 6 hours after Bax c-myc induction, and cells collected after 2 hours. Bax c-myc was immunoprecipitated using the protocol described above, loaded onto two SDS-PAGE gels and blotted. One membrane was exposed to autoradiography film, and the other was probed with a polyclonal anti-Bax antibody.
Results
Mammalian PKC enhances Bax c-myc-induced cell death without disturbing plasma membrane integrity
Bax  needs to be activated in order to induce organelle membrane permeabilization, and thus trigger apoptosis. So, expression of native human Bax in yeast, a system that lacks several homologues of mammalian apoptotic regulators, has no effect on yeast viability [43] . Therefore, in order to study the effect of mammalian PKC in the regulation of Bax using yeast, we expressed a form of Bax in the active conformation that is cytotoxic for this organism (Bax cmyc) [35] . Our results show that cell death induced by expression of Bax c-myc in yeast is increased by co-expression with PKC ( Fig. 1A) . This increase in cell death is not accompanied by loss of plasma membrane integrity, measured by PI staining (Fig. 1B) . The maintenance of plasma membrane integrity suggests that, as already described for expression of Bax c-myc alone [44] , the death process in cells co-expressing PKC and Bax c-myc is a regulated event.
Expression of PKC enhances Bax c-myc-induced ROS production, cyt c release and mitochondrial network fragmentation
Yeast cell death induced by Bax c-myc is usually accompanied by several functional and biochemical markers such as ROS production [38, 45] , cyt c release [40] , and fragmentation of the mitochondrial network [44] . The effect of PKC in Bax c-myc ROS production, cyt c release, and fragmentation of the mitochondrial network was evaluated in cells co-expressing PKC and Bax c-myc and compared to cells expressing Bax c-myc alone. ROS production increases in cells co-expressing PKC and Bax c-myc ( Fig. 2A ). In addition, cells co-expressing PKC and Bax c-myc have a lower cyt c content ( Fig. 2B ) and increased mitochondrial network fragmentation (Fig. 2C,D) . These results indicate that PKC enhances the cytotoxic effects of Bax c-myc expression in yeast cells.
Co-expression of PKC and Bax c-myc stimulates autophagy
An increased amount of Atg8p has been observed in yeast following nitrogen starvation, rapamycin treatment or Bax c-myc expression. The increase in the amount of this autophagic protein is considered one of the typical markers of autophagy induction [44, 46] . In order to determine whether PKC also interferes with Bax c-myc-induced autophagy, Atg8p expression was evaluated by western blot in cells expressing PKC, Bax c-myc, co-expressing PKC and
Bax c-myc, and in control cells. It has been previously shown that Bax c-myc stimulates Atg8p expression [44] . Accordingly we were also able to detect a two-fold increase in Atg8p expression after Bax c-myc expression. However we did not detect any difference in Atg8p expression between control cells and PKC expressing cells (Fig. 3A) . In cells co-expressing both proteins there was a seven-fold increase in Atg8p expression, indicating that autophagy is increased.
In order to further confirm that the higher Atg8p expression detected was associated to autophagy induction we also monitored the level of Atg8p that is delivered into the vacuole. For this purpose a GFP-Atg8p fusion was also expressed in our transformed cells. When this fusion is delivered into the vacuole the Atg8p is rapidly degraded by vacuolar hydrolases while free GFP is not degraded. So, accumulation of the GFP moiety reflects delivery of Atg8p into the vacuole and therefore the level of autophagy induction [36] . Cells expressing the GFP-Atg8p fusion displayed an accumulation of free GFP corresponding to 7% and 15% of the total GFP, when Bax c-myc is expressed, or PKC and Bax c-myc are co-expressed, respectively. These observations indicate a higher delivery of Atg8p into the vacuole and confirmed a higher autophagy level when both proteins are co-expressed ( Fig. 3B ). In control cells and in cells expressing PKC no accumulation of free GFP was detected (Fig. 3B) .
PKC increases the insertion of Bax c-myc into the mitochondrial membrane
When expressed in yeast cells, Bax c-myc translocates to the mitochondria and inserts into the mitochondrial membrane, leading to several downstream events described above. The presence of PKC and Bax c-myc in whole cell extracts and in the mitochondrial fraction was verified by western blot. Both proteins were expressed in yeast cells, and there was an accumulation of Bax c-myc (about 2.3 times) in cells co-expressing PKC (Fig. 4A ). The possibility that this increase could be due to interference by PKC with the promoter of Bax c-myc was unlikely. However we did check this possibility by expressing PKC with Bcl-xL, another protein with mitochondrial localization, under control of the same expression system (pCM184) used for Bax c-myc expression. We could confirm that there was no effect on the expression of Bcl-xL, thus ruling out the hypothesis of a non-specific effect of PKC on the promoter of the plasmid used for Bax c-myc expression (data not shown). Analysis of the mitochondrial fraction confirmed the translocation of Bax c-myc to the mitochondria as revealed by an increase in the amount of Bax c-myc in the mitochondrial fraction (about 4.6 times) when PKC is co-expressed (Fig. 4A ).
This increase is much higher than that observed in whole cell extracts, indicating that the accumulation of Bax c-myc observed under co-expression conditions occurs preferably at mitochondria. In fact, the accumulation observed in whole cell extracts might be due to a higher translocation to mitochondria since Bax c-myc is more protected from degradation in the lipidic environment of the outer mitochondrial membrane.
PKC could lead to an increase in the actual insertion of Bax c-myc into the mitochondrial membrane or only to an enhanced association. Isolated mitochondria from cells expressing Bax c-myc or co-expressing PKC and Bax c-myc were therefore treated with Na 2 CO 3 or Triton X-100 to remove loosely bound or inserted proteins, respectively. Bax c-myc was partially insensitive to carbonate treatment but sensitive to Triton X-100, showing that it is mainly inserted into the mitochondrial membrane (Fig. 4B ). The maintenance of the ratio between associated and inserted Bax c-myc in yeast cells expressing Bax c-myc and co-expressing PKC
and Bax c-myc shows that the higher translocation of this protein is associated with a higher insertion.
Analysis of the mitochondrial fraction also revealed the presence of PKC in mitochondria independently of the co-expression with Bax c-myc (Fig. 4C ).
PKC does not alter Bax c-myc phosphorylation in yeast
Arokium et al. [41] showed that human Bax  is phosphorylated in yeast cells and mutation of possible phosphorylation serine sites in the protein enhances the ability of Bax  to insert into the mitochondria and to induce cyt c release. Interestingly, we were not able to detect phosphorylation of Bax c-myc either in cells expressing Bax c-myc or co-expressing PKC and Bax c-myc, using an antibody previously shown to detect Bax  with phosphorylated serines [5] .
As a positive control, Bax  immunoprecipitated from yeast cells was used (Fig. 5A ). To confirm that Bax c-myc is not phosphorylated in yeast cells, in vivo radioactive labelling was performed. Phosphorylation of Bax c-myc was not detected, with or without expression of PKC ( Fig. 5B) . These results indicate that the higher insertion of Bax c-myc in the presence of PKC, and its associated effect described above is not related to an alteration of the Bax c-myc phosphorylation state.
PKC kinase activity is not involved in enhancing the effect of Bax c-myc
To study the relation between PKC kinase activity and the enhancement of the events induced by Bax c-myc, the viability of yeast cells expressing both proteins was assessed in the presence of two PKC inhibitors, Gö 6976 and Ro 32-0432. The concentration of both inhibitors tested was selected using a yeast phenotypic assay as described in [47] . Curiously, the results obtained showed that these inhibitors have no effect on the viability of yeast cells expressing both proteins ( Fig. 6A) . A catalytically inactive mutant of PKC (the PKC K368R ) was also co-expressed with Bax c-myc and its effect on cell viability compared with that obtained with wild-type PKC. In this mutant, a lysine residue in the ATP-binding site of the protein was replaced with an arginine, leading to the loss of phosphorylation activity [48] . Co-expression of PKC K368R and Bax c-myc was confirmed by western blot (data not shown). Co-expression of PKC K368R or PKC with Bax c-myc had similar effects in cell viability (Fig. 6B) . These results indicate that the effect of PKC on Bax c-myc expressing yeast cells does not depend on PKC kinase activity.
Discussion
In previous studies, we took advantage of yeast to study the role of mammalian PKC isoforms on the regulation of apoptosis and the Bcl-2 anti-apoptotic protein Bcl-xL [49] . In the present work, yeast was used to study the role of PKC on the regulation of Bax, one of the most important proteins in the mitochondrial apoptotic cascade. We assessed whether PKC, a member of the classical PKC subfamily, modulates Bax without the interference of other Bcl-2 family proteins and PKC isoforms by expressing these two proteins in yeast.
In this work, we show that PKC regulates the effect of Bax c-myc, an active form of Bax , by increasing its translocation and insertion into the outer mitocondrial membrane. This leads to an enhancement of other Bax c-myc induced-downstream events in yeast cells, such as loss of viability, ROS production, mitochondrial network fragmentation, cyt c release, and higher Atg8p expression and vacuolar delivery. In contrast, no increase in loss of plasma membrane integrity was detected. Several reports show that autophagy is activated following Bax c-myc expression [38, 44] . These authors showed that autophagy was not responsible for the loss of plating efficiency but rather played a minor role in maintaining cell survival. However, they found that mitophagy is required for regulated loss of cell survival since absence of Uth1p (a protein required for mitophagy) led to a higher percentage of PI-positive cells. Here, the enhancement of PKC. This shows that the kinase activity of PKC is not necessary for the enhancement of Bax c-myc induced cell death and that a phosphorylation cascade is not involved in this process. It has previously been shown that PKC enhances phosphorylation of Bcl-xL in yeast, abolishing its anti-apoptotic activity [49] . Here we show that PKC also has a pro-apoptotic role in the modulation of Bax. However, this role is independent of its kinase activity, in contrast with the pro-apoptotic role observed for the modulation of Bcl-xL. It was reported that PKC interacts with Bax, sequestering it in the cytosol. It is possible that a similar interaction between Bax cmyc and PKCexists in this compartment or even at mitochondria. However, we could not detect it by immunoprecipitation (data not shown). The present study only focused on the regulation of Bax c-myc by PKC. However we expect that isoforms from other PKC subfamilies may regulate Bax differently. Actually, specific modulation by distinct PKC isoforms of the Bcl-2 protein family member Bcl-xL has already been reported [49] .
In conclusion, our findings show that PKC has a pro-apoptotic effect on Bax c-myc, increasing Bax c-myc induced cell death, translocation and insertion of Bax c-myc into the outer mitochondrial membrane, and enhances several other cellular events associated with Bax c-mycinduced death. We therefore propose a model where PKC aids in the translocation and/or the insertion of Bax c-myc into the outer mitochondrial membrane by a still unknown mechanism, subsequently leading to an increase in cyt c release, ROS production, mitochondrial network fragmentation and cell death. Furthermore, an increase in the autophagic process allows the maintenance of a regulated form of cell death. This work together with our previous data on specific modulation of apoptosis and Bcl-xL phosphorylation by distinct mammalian PKC isoforms [49] further reinforces the yeast model to study the regulation of Bcl-2 family proteins by PKC isoforms. Finally, a mechanistic insight on apoptosis regulation by PKC through regulation of Bax insertion into mitochondria is provided. 
Figure legends
Figure 6
The effect of PKC is independent of its kinase activity. 
Figure 7
Proposed model for PKC regulation of Bax c-myc induced cell death. PKC in the cytosol, mitochondria or in both compartments directly or indirectly increases translocation and/or insertion of Bax c-myc to mitochondria by an unknown mechanism leading to an increase in cyt c release, ROS production and mitochondrial network fragmentation. These alterations lead to an increase in autophagy that regulates the mode of cell death.
